Benzinga | Apr 29, 2021 04:47PM EDT

ResMed Q3 EPS $1.30 Beats $1.28 Estimate, Sales $768.80M Miss $801.83M Estimate

ResMed (NYSE:RMD) reported quarterly earnings of $1.30 per share which beat the analyst consensus estimate of $1.28 by 1.56 percent. This is a 0.78 percent increase over earnings of $1.29 per share from the same period last year. The company reported quarterly sales of $768.80 million which missed the analyst consensus estimate of $801.83 million by 4.12 percent. This is a 0.09 percent decrease over sales of $769.46 million the same period last year.